Can PSA derivatives reduce unnecessary prostate MRI after negative biopsy? Learn how simple markers may guide imaging ...
Mount Sinai advances prostate care with AI-powered therapy designed to preserve continence and sexual function The Mount Sinai Hospital is ranked ...
Koelis, SAS ("Koelis" or the "Company", a leader and innovator in MRI-ultrasound fusion guidance for prostate cancer interventions, recently announced that the Centers for Medicare & Medicaid ...
Presented at the American Urological Association's 2025 Annual Meeting, this new data builds on Avenda Health's previous study demonstrating Unfold AI's ability to predict extracapsular extension risk ...
Among patients with prostate cancer who received MRI-guided stereotactic body radiation therapy (SABR), more than 80% demonstrated “classic” neurovascular bundle patterns and over 96% showed more than ...
Despite technologic advances and guideline recommendations, prostate MRI still lacks the accuracy to replace biopsies in active surveillance, data on almost 2,000 patients suggested. MRI had a 75% ...
Through GE Healthcare's AI Innovation Lab, Mass General Brigham and UW-Madison will pair the company's magnetic resonance imaging foundational model with real data from their hospital systems and then ...
Vista AI, Inc., the leader in automated MRI scanning software for hospitals and imaging centers, today announced the closing of $29.5 million in Series B financing. New investors include Cedars-Sinai ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback